Overview
Continuous salivary secretion, often manifesting as drooling, can significantly impact the quality of life for affected individuals, particularly those with neurological disorders, congenital anomalies, or those requiring tracheotomies. This condition not only poses aesthetic and social challenges but also carries clinical implications such as chronic aspiration, hypoxemia, and recurrent respiratory infections. Effective management requires a comprehensive approach that includes accurate assessment tools, targeted interventions, and vigilant follow-up to monitor outcomes and adjust treatments as necessary. The evidence reviewed here highlights the utility of specific scales and diagnostic techniques in guiding clinical practice, particularly in pediatric populations with tracheotomies.
Clinical Presentation
The clinical presentation of continuous salivary secretion typically includes overt drooling, which can vary in severity and frequency. A study by [PMID:26092552] demonstrated a high level of agreement between the Drooling Quotient (DQ) and the Drooling Severity and Frequency Scale (DSFS), underscoring the reliability of DSFS as a practical tool for clinicians. This scale, easily administered by caregivers, correlates well with more complex quantitative measures, making it invaluable in routine clinical settings where invasive assessments might not be feasible. Beyond drooling, patients often exhibit additional symptoms indicative of underlying complications. For instance, a study focusing on pediatric patients with tracheotomies [PMID:11389254] reported chronic congestion and persistent hypoxemia, suggesting that these signs are common manifestations of chronic salivary aspiration. These symptoms not only reflect the physical burden of excessive saliva but also highlight the potential for serious respiratory complications, emphasizing the need for early and accurate diagnosis.
Diagnosis
Accurate diagnosis of continuous salivary secretion and its complications is crucial for effective management. The DSFS, validated through its correlation with the Drooling Quotient [PMID:26092552], serves as a reliable initial screening tool in clinical practice. Parents and caregivers can effectively use this scale to report symptoms, providing clinicians with a quantitative basis for intervention planning. For more definitive diagnosis, particularly in cases involving tracheotomies, advanced imaging techniques such as radionuclide salivagram have proven invaluable. The study by [PMID:11389254] utilized this method to confirm chronic aspiration of saliva, offering a clear diagnostic pathway for patients where clinical symptoms alone might be ambiguous. This diagnostic approach ensures that interventions are targeted towards addressing the root cause of symptoms, thereby improving patient outcomes.
Management
Effective management of continuous salivary secretion involves a multifaceted approach tailored to the individual patient's needs. The DSFS, due to its ease of use and accuracy [PMID:26092552], is recommended as a monitoring tool to assess the efficacy of various interventions aimed at reducing drooling. Interventions may include pharmacological treatments, physical therapies, and supportive devices designed to manage saliva production and flow. In specific populations, such as pediatric patients with tracheotomies [PMID:11389254], non-invasive respiratory support methods have shown promising results. For example, the use of Continuous Positive Airway Pressure (CPAP) in these patients led to a significant reduction in salivary aspiration, as evidenced by radionuclide salivagram findings and clinical improvements, including fewer hospitalizations for respiratory issues. This underscores the importance of considering respiratory support strategies alongside traditional drool management techniques to address both symptoms and underlying complications effectively.
Pharmacological Interventions
Non-Pharmacological Approaches
Prognosis & Follow-up
The prognosis for patients with continuous salivary secretion largely depends on the underlying cause and the effectiveness of the management strategies employed. In the context of pediatric patients with tracheotomies treated with CPAP [PMID:11389254], the follow-up data indicated a marked improvement in clinical symptoms, with reduced frequency of respiratory-related hospitalizations. This suggests that with appropriate interventions, the prognosis can be significantly improved, leading to better quality of life and fewer complications. Regular follow-up assessments using tools like the DSFS are essential to monitor symptom progression and treatment efficacy, allowing for timely adjustments to the management plan. Clinicians should remain vigilant for signs of recurrent aspiration or other respiratory issues, ensuring that patients continue to benefit from ongoing care.
Key Recommendations
References
1 Rashnoo P, Daniel SJ. Drooling quantification: Correlation of different techniques. International journal of pediatric otorhinolaryngology 2015. link 2 Finder JD, Yellon R, Charron M. Successful management of tracheotomized patients with chronic saliva aspiration by use of constant positive airway pressure. Pediatrics 2001. link
2 papers cited of 4 indexed.